Taylor Wessing LLP

The ‘helpful, knowledgeable, and collaborative’ team at Taylor Wessing LLP  showcases a diverse range of expertise, particularly in venture capital transactions within the biotech sector, patent litigation and advisory work for growth companies. Alison Dennis co-leads the practice and frequently leverages her broad knowledge in IP, compliance and contractual issues to advise pharmaceutical clients and medical device manufacturers. Fellow co-head Andrew Edge has extensive experience in public and private mergers and acquisitions, IPOs and secondary offerings. Nigel Stoate excels in patent litigation and frequently co-ordinates multi-jurisdictional cases. In Cambridge, Ross McNaughton focuses on the biotech domain, primarily supporting clients with corporate advice and capital raising. His Cambridge colleague Adrian Toutoungi, with his particular experience in biologics and small-molecule therapeutics, advises on life science licensing mandates. Colin McCall also assists clients with licensing agreements and R&D projects, while Charlie Adams frequently brings his IP knowledge to bear on work with life sciences incubators and accelerators.